{"tool_name":"masi","contents":["biotools","bioschemas"],"fetched_metadata":{"biotools":{"id":"masi","home":"http://www.aiddlab.com/MASI","summary":"Microbiota-active substance interactions database.\nActive Substance Interaction database.\nTry Examples: Bifidobacterium adolescentis, Enterococcus faecalis, Acarbose, Caffeic acid, Oxaprozin, Obesity, Colorectal cancer.\n\nA centralized and standardized database to catalog Microbiota-Active Substance Interaction (MASI) will be very useful for related research fields, including microbiota-related precision medicine, pharmaceutical research, food and nutrition research, clinical pharmacy, health management studies.\n\nAccumulating evidence about the interaction between human microbiota and active substances, especially for those therapeutically-relevant substances such as clinical used drugs and traditional medicines/herbs, is deepenning our understanding in the role of \"our second genome\" in human health and diseases, and opens new avenue for managing/treating human healthy problems/diseases by manipulating microbiota-human interactions.","addition_date":"2021-01-18T11:13:33Z","last_update_date":"2024-11-24T20:42:33.980918Z","tool_type":["Web service"]},"bioschemas":{"name":"MASI","home":"https://bio.tools/masi","summary":"Microbiota-active substance interactions database.\nActive Substance Interaction database.\nTry Examples: Bifidobacterium adolescentis, Enterococcus faecalis, Acarbose, Caffeic acid, Oxaprozin, Obesity, Colorectal cancer.\n\nA centralized and standardized database to catalog Microbiota-Active Substance Interaction (MASI) will be very useful for related research fields, including microbiota-related precision medicine, pharmaceutical research, food and nutrition research, clinical pharmacy, health management studies.\n\nAccumulating evidence about the interaction between human microbiota and active substances, especially for those therapeutically-relevant substances such as clinical used drugs and traditional medicines/herbs, is deepenning our understanding in the role of \"our second genome\" in human health and diseases, and opens new avenue for managing/treating human healthy problems/diseases by manipulating microbiota-human interactions.","tool_type":"sc:SoftwareApplication"}}}